0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Oral Artemether Drugs Market Research Report 2026
Published Date: 2026-03-14
|
Report Code: QYRE-Auto-35S17808
Home | Market Reports
Global Oral Artemether Drugs Market Research Report 2024
BUY CHAPTERS

Global Oral Artemether Drugs Market Research Report 2026

Code: QYRE-Auto-35S17808
Report
2026-03-14
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Oral Artemether Drugs Market

The global Oral Artemether Drugs market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Oral artemether refers to oral medications made with artemether as the main ingredient, such as artemether tablets and artemether capsules. Artemether is a medication primarily used for the treatment of malaria. It belongs to the class of drugs known as artemisinin derivatives, which are derived from the plant Artemisia annua (sweet wormwood).
The North American market for Oral Artemether Drugs is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Oral Artemether Drugs is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Oral Artemether Drugs in Hospital Pharmacy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Oral Artemether Drugs include Novartis, KPC Pharmaceuticals, Ipca Laboratories, AdvaCare Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Oral Artemether Drugs market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Oral Artemether Drugs. The Oral Artemether Drugs market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Oral Artemether Drugs market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Oral Artemether Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Oral Artemether Drugs Market Report

Report Metric Details
Report Name Oral Artemether Drugs Market
Segment by Type
  • Artemether Tablets
  • Artemether Capsules
Segment by Application
  • Hospital Pharmacy
  • Retail Pharmacy
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Novartis, KPC Pharmaceuticals, Ipca Laboratories, AdvaCare Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Oral Artemether Drugs companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Oral Artemether Drugs Market report?

Ans: The main players in the Oral Artemether Drugs Market are Novartis, KPC Pharmaceuticals, Ipca Laboratories, AdvaCare Pharma

What are the Application segmentation covered in the Oral Artemether Drugs Market report?

Ans: The Applications covered in the Oral Artemether Drugs Market report are Hospital Pharmacy, Retail Pharmacy

What are the Type segmentation covered in the Oral Artemether Drugs Market report?

Ans: The Types covered in the Oral Artemether Drugs Market report are Artemether Tablets, Artemether Capsules

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral Artemether Drugs Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Artemether Tablets
1.2.3 Artemether Capsules
1.3 Market by Application
1.3.1 Global Oral Artemether Drugs Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oral Artemether Drugs Market Perspective (2021–2032)
2.2 Global Oral Artemether Drugs Growth Trends by Region
2.2.1 Global Oral Artemether Drugs Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Oral Artemether Drugs Historic Market Size by Region (2021–2026)
2.2.3 Oral Artemether Drugs Forecasted Market Size by Region (2027–2032)
2.3 Oral Artemether Drugs Market Dynamics
2.3.1 Oral Artemether Drugs Industry Trends
2.3.2 Oral Artemether Drugs Market Drivers
2.3.3 Oral Artemether Drugs Market Challenges
2.3.4 Oral Artemether Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oral Artemether Drugs Players by Revenue
3.1.1 Global Top Oral Artemether Drugs Players by Revenue (2021–2026)
3.1.2 Global Oral Artemether Drugs Revenue Market Share by Players (2021–2026)
3.2 Global Top Oral Artemether Drugs Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Oral Artemether Drugs Revenue
3.4 Global Oral Artemether Drugs Market Concentration Ratio
3.4.1 Global Oral Artemether Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Artemether Drugs Revenue in 2025
3.5 Global Key Players of Oral Artemether Drugs Head Offices and Areas Served
3.6 Global Key Players of Oral Artemether Drugs, Products and Applications
3.7 Global Key Players of Oral Artemether Drugs, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Oral Artemether Drugs Breakdown Data by Type
4.1 Global Oral Artemether Drugs Historic Market Size by Type (2021–2026)
4.2 Global Oral Artemether Drugs Forecasted Market Size by Type (2027–2032)
5 Oral Artemether Drugs Breakdown Data by Application
5.1 Global Oral Artemether Drugs Historic Market Size by Application (2021–2026)
5.2 Global Oral Artemether Drugs Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Oral Artemether Drugs Market Size (2021–2032)
6.2 North America Oral Artemether Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Oral Artemether Drugs Market Size by Country (2021–2026)
6.4 North America Oral Artemether Drugs Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oral Artemether Drugs Market Size (2021–2032)
7.2 Europe Oral Artemether Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Oral Artemether Drugs Market Size by Country (2021–2026)
7.4 Europe Oral Artemether Drugs Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Oral Artemether Drugs Market Size (2021–2032)
8.2 Asia-Pacific Oral Artemether Drugs Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Oral Artemether Drugs Market Size by Region (2021–2026)
8.4 Asia-Pacific Oral Artemether Drugs Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Oral Artemether Drugs Market Size (2021–2032)
9.2 Latin America Oral Artemether Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Oral Artemether Drugs Market Size by Country (2021–2026)
9.4 Latin America Oral Artemether Drugs Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oral Artemether Drugs Market Size (2021–2032)
10.2 Middle East & Africa Oral Artemether Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Oral Artemether Drugs Market Size by Country (2021–2026)
10.4 Middle East & Africa Oral Artemether Drugs Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Oral Artemether Drugs Introduction
11.1.4 Novartis Revenue in Oral Artemether Drugs Business (2021–2026)
11.1.5 Novartis Recent Development
11.2 KPC Pharmaceuticals
11.2.1 KPC Pharmaceuticals Company Details
11.2.2 KPC Pharmaceuticals Business Overview
11.2.3 KPC Pharmaceuticals Oral Artemether Drugs Introduction
11.2.4 KPC Pharmaceuticals Revenue in Oral Artemether Drugs Business (2021–2026)
11.2.5 KPC Pharmaceuticals Recent Development
11.3 Ipca Laboratories
11.3.1 Ipca Laboratories Company Details
11.3.2 Ipca Laboratories Business Overview
11.3.3 Ipca Laboratories Oral Artemether Drugs Introduction
11.3.4 Ipca Laboratories Revenue in Oral Artemether Drugs Business (2021–2026)
11.3.5 Ipca Laboratories Recent Development
11.4 AdvaCare Pharma
11.4.1 AdvaCare Pharma Company Details
11.4.2 AdvaCare Pharma Business Overview
11.4.3 AdvaCare Pharma Oral Artemether Drugs Introduction
11.4.4 AdvaCare Pharma Revenue in Oral Artemether Drugs Business (2021–2026)
11.4.5 AdvaCare Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Oral Artemether Drugs Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Artemether Tablets
 Table 3. Key Players of Artemether Capsules
 Table 4. Global Oral Artemether Drugs Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 5. Global Oral Artemether Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Oral Artemether Drugs Market Size by Region (US$ Million), 2021–2026
 Table 7. Global Oral Artemether Drugs Market Share by Region (2021–2026)
 Table 8. Global Oral Artemether Drugs Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 9. Global Oral Artemether Drugs Market Share by Region (2027–2032)
 Table 10. Oral Artemether Drugs Market Trends
 Table 11. Oral Artemether Drugs Market Drivers
 Table 12. Oral Artemether Drugs Market Challenges
 Table 13. Oral Artemether Drugs Market Restraints
 Table 14. Global Oral Artemether Drugs Revenue by Players (US$ Million), 2021–2026
 Table 15. Global Oral Artemether Drugs Market Share by Players (2021–2026)
 Table 16. Global Top Oral Artemether Drugs Players by Tier (Tier 1, Tier 2, and Tier 3), based on Oral Artemether Drugs Revenue, 2025
 Table 17. Ranking of Global Top Oral Artemether Drugs Companies by Revenue (US$ Million) in 2025
 Table 18. Global 5 Largest Players Market Share by Oral Artemether Drugs Revenue (CR5 and HHI), 2021–2026
 Table 19. Global Key Players of Oral Artemether Drugs, Headquarters and Area Served
 Table 20. Global Key Players of Oral Artemether Drugs, Products and Applications
 Table 21. Global Key Players of Oral Artemether Drugs, Date of General Availability (GA)
 Table 22. Mergers and Acquisitions, Expansion Plans
 Table 23. Global Oral Artemether Drugs Market Size by Type (US$ Million), 2021–2026
 Table 24. Global Oral Artemether Drugs Revenue Market Share by Type (2021–2026)
 Table 25. Global Oral Artemether Drugs Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 26. Global Oral Artemether Drugs Revenue Market Share by Type (2027–2032)
 Table 27. Global Oral Artemether Drugs Market Size by Application (US$ Million), 2021–2026
 Table 28. Global Oral Artemether Drugs Revenue Market Share by Application (2021–2026)
 Table 29. Global Oral Artemether Drugs Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 30. Global Oral Artemether Drugs Revenue Market Share by Application (2027–2032)
 Table 31. North America Oral Artemether Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 32. North America Oral Artemether Drugs Market Size by Country (US$ Million), 2021–2026
 Table 33. North America Oral Artemether Drugs Market Size by Country (US$ Million), 2027–2032
 Table 34. Europe Oral Artemether Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 35. Europe Oral Artemether Drugs Market Size by Country (US$ Million), 2021–2026
 Table 36. Europe Oral Artemether Drugs Market Size by Country (US$ Million), 2027–2032
 Table 37. Asia-Pacific Oral Artemether Drugs Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 38. Asia-Pacific Oral Artemether Drugs Market Size by Region (US$ Million), 2021–2026
 Table 39. Asia-Pacific Oral Artemether Drugs Market Size by Region (US$ Million), 2027–2032
 Table 40. Latin America Oral Artemether Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 41. Latin America Oral Artemether Drugs Market Size by Country (US$ Million), 2021–2026
 Table 42. Latin America Oral Artemether Drugs Market Size by Country (US$ Million), 2027–2032
 Table 43. Middle East & Africa Oral Artemether Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Middle East & Africa Oral Artemether Drugs Market Size by Country (US$ Million), 2021–2026
 Table 45. Middle East & Africa Oral Artemether Drugs Market Size by Country (US$ Million), 2027–2032
 Table 46. Novartis Company Details
 Table 47. Novartis Business Overview
 Table 48. Novartis Oral Artemether Drugs Product
 Table 49. Novartis Revenue in Oral Artemether Drugs Business (US$ Million), 2021–2026
 Table 50. Novartis Recent Development
 Table 51. KPC Pharmaceuticals Company Details
 Table 52. KPC Pharmaceuticals Business Overview
 Table 53. KPC Pharmaceuticals Oral Artemether Drugs Product
 Table 54. KPC Pharmaceuticals Revenue in Oral Artemether Drugs Business (US$ Million), 2021–2026
 Table 55. KPC Pharmaceuticals Recent Development
 Table 56. Ipca Laboratories Company Details
 Table 57. Ipca Laboratories Business Overview
 Table 58. Ipca Laboratories Oral Artemether Drugs Product
 Table 59. Ipca Laboratories Revenue in Oral Artemether Drugs Business (US$ Million), 2021–2026
 Table 60. Ipca Laboratories Recent Development
 Table 61. AdvaCare Pharma Company Details
 Table 62. AdvaCare Pharma Business Overview
 Table 63. AdvaCare Pharma Oral Artemether Drugs Product
 Table 64. AdvaCare Pharma Revenue in Oral Artemether Drugs Business (US$ Million), 2021–2026
 Table 65. AdvaCare Pharma Recent Development
 Table 66. Research Programs/Design for This Report
 Table 67. Key Data Information from Secondary Sources
 Table 68. Key Data Information from Primary Sources
 Table 69. Authors List of This Report


List of Figures
 Figure 1. Oral Artemether Drugs Picture
 Figure 2. Global Oral Artemether Drugs Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Oral Artemether Drugs Market Share by Type: 2025 vs 2032
 Figure 4. Artemether Tablets Features
 Figure 5. Artemether Capsules Features
 Figure 6. Global Oral Artemether Drugs Market Size by Application (US$ Million), 2021–2032
 Figure 7. Global Oral Artemether Drugs Market Share by Application: 2025 vs 2032
 Figure 8. Hospital Pharmacy Case Studies
 Figure 9. Retail Pharmacy Case Studies
 Figure 10. Oral Artemether Drugs Report Years Considered
 Figure 11. Global Oral Artemether Drugs Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 12. Global Oral Artemether Drugs Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Oral Artemether Drugs Market Share by Region: 2025 vs 2032
 Figure 14. Global Oral Artemether Drugs Market Share by Players in 2025
 Figure 15. Global Oral Artemether Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 16. The Top 10 and 5 Players Market Share by Oral Artemether Drugs Revenue in 2025
 Figure 17. North America Oral Artemether Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 18. North America Oral Artemether Drugs Market Share by Country (2021–2032)
 Figure 19. United States Oral Artemether Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 20. Canada Oral Artemether Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. Europe Oral Artemether Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Europe Oral Artemether Drugs Market Share by Country (2021–2032)
 Figure 23. Germany Oral Artemether Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. France Oral Artemether Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. U.K. Oral Artemether Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. Italy Oral Artemether Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. Russia Oral Artemether Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Ireland Oral Artemether Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Asia-Pacific Oral Artemether Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Asia-Pacific Oral Artemether Drugs Market Share by Region (2021–2032)
 Figure 31. China Oral Artemether Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Japan Oral Artemether Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. South Korea Oral Artemether Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Southeast Asia Oral Artemether Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. India Oral Artemether Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Australia & New Zealand Oral Artemether Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Latin America Oral Artemether Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Latin America Oral Artemether Drugs Market Share by Country (2021–2032)
 Figure 39. Mexico Oral Artemether Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Brazil Oral Artemether Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Middle East & Africa Oral Artemether Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Middle East & Africa Oral Artemether Drugs Market Share by Country (2021–2032)
 Figure 43. Israel Oral Artemether Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Saudi Arabia Oral Artemether Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. UAE Oral Artemether Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Novartis Revenue Growth Rate in Oral Artemether Drugs Business (2021–2026)
 Figure 47. KPC Pharmaceuticals Revenue Growth Rate in Oral Artemether Drugs Business (2021–2026)
 Figure 48. Ipca Laboratories Revenue Growth Rate in Oral Artemether Drugs Business (2021–2026)
 Figure 49. AdvaCare Pharma Revenue Growth Rate in Oral Artemether Drugs Business (2021–2026)
 Figure 50. Bottom-up and Top-down Approaches for This Report
 Figure 51. Data Triangulation
 Figure 52. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS